Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
about
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines.CD8 T cell competition for dendritic cells in vivo is an early event in activation.Adoptive cell transfer therapyAutoimmune response to transthyretin in juvenile idiopathic arthritis.Multiple vaccinations: friend or foe.Sentinel lymph node biopsy for melanoma: indications and rationale.Multipeptide vaccination in cancer patients.Improving T cell responses to modified peptides in tumor vaccinesRoutine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.The new normal: immunomodulatory agents against sepsis immune suppression.TAA polyepitope DNA-based vaccines: a potential tool for cancer therapyProspect and progress of personalized peptide vaccinations for advanced cancers.A melanoma multiepitope polypeptide induces specific CD8+ T-cell response.Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant.Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience
P2860
Q30425111-0DE31A48-B619-4825-8808-D4CA6610C28EQ30429708-DD418CE4-B979-47D7-9BEC-8273514850B2Q34882567-84E2B2F2-6DE7-46F0-9612-71D1663CAAA4Q36380249-80E59C1A-D2BF-402A-B92B-8CBD12D5C292Q36669011-7FC62FE9-DF0B-4507-82DC-365FFB783B4FQ36734688-CDD127F6-DCC0-49FC-9865-8562B3FAF499Q37531858-69776D57-EA8D-48D1-90B4-607B85E1F929Q37547268-05505AB3-C6DA-43A6-BBC3-760FAF695E10Q37634253-4565B45F-4DBE-41B8-9C7C-853340091B4BQ37683228-D59EEA1C-78C8-44C6-9A46-EF7EA61E88F1Q37686624-87C6AC84-5279-4DC0-AF26-F3260DAB1311Q37771268-9AF16B54-24D7-4670-BDCD-C2EB3F13A4D4Q38758988-79F1D36C-167F-4C07-8E3C-0B2AC397966DQ38845278-75531DBC-29A8-4BDA-97A9-C4BBC8046361Q38982143-F691E6FC-13F4-4290-BA02-87679FF98474Q39117175-800ED5EB-4BAD-47C7-A6FE-9A67C6D7B30DQ39982625-88ED7106-4E28-4006-8226-C31D5262BB92Q46193557-D91487DE-FA7C-453F-A514-29C44652AEB5Q57537530-560392E1-A35B-4B63-8460-38E4F60D0C9C
P2860
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Altered CD8
@nl
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@ast
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@en
type
label
Altered CD8
@nl
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@ast
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@en
prefLabel
Altered CD8
@nl
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@ast
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@en
P2093
P2860
P1476
Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines
@en
P2093
Donald E White
James C Yang
Kathleen E Morton
Lien T Ngo
Marybeth S Hughes
Richard E Royal
Richard M Sherry
Sharon A Mavroukakis
Steven A Rosenberg
Susan L Schwarz
P2860
P304
P356
10.1097/01.CJI.0000190399.98802.10
P577
2006-03-01T00:00:00Z